Literature DB >> 29303952

Voltage-gated Potassium Channel Antibody Autoimmune Encephalopathy Presenting With Isolated Psychosis in an Adolescent.

Natalie C Pon1, Kimberly M Houck, Eyal Muscal, Sindhu A Idicula.   

Abstract

Antibody-mediated encephalopathies associated with serum or cerebrospinal fluid antibodies directed against neuronal structures may present with a multitude of neuropsychiatric syndromes. Although some of the antibody-driven conditions are now well recognized in adults (eg, N-methyl-D-aspartate receptor antibody encephalitis), the spectrum of neuropsychiatric manifestations in the pediatric population is less clear. Psychosis, confusion, catatonia, and additional behavioral changes, along with seizures, encephalopathy, and movement disorders, may be initial manifestations or concurrent features in all age groups. Psychosis, when present, is often part of a broader spectrum of neurological and neuropsychiatric symptoms for which the diagnosis of autoimmune encephalitis is considered. The authors present the case of an adolescent with an acute and isolated psychotic presentation of voltage-gated potassium channel antibody encephalitis, further expanding the phenotypic spectrum of this specific antibody-mediated disease and raising the possibility that specific immune-mediated processes may define a biological subgroup of psychoses.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29303952     DOI: 10.1097/PRA.0000000000000265

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  2 in total

1.  Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum.

Authors:  Joo Hee Seo; Yun-Jin Lee; Ki Hyeong Lee; Elakkat Gireesh; Holly Skinner; Michael Westerveld
Journal:  Clin Exp Pediatr       Date:  2019-08-16

2.  N-Methyl-D-Aspartate(NMDA) Receptor and Voltage-Gated Potassium Channel (VGKC) Antibody-Associated Encephalitides Presenting as First Episode Acute Psychosis.

Authors:  Charmaine Tang; Kevin Tan; Geraldine Lim; Lynnette Tan; Kay Yaw Tay; Nagaendran Kandiah; Edimansyah Abdin; Swapna K Verma
Journal:  Front Psychiatry       Date:  2019-12-13       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.